NI
KPTI icon

Numeric Investors’s Karyopharm Therapeutics KPTI Stock Holding History

Numeric Investors’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,855
Closed -$382K – 1097
2016
Q1 		$382K Buy
+2,855
New +$315K ﹤0.01% 788
2015
Q1 		– Sell
-507
Closed -$284K – 968
2014
Q4 		$284K Buy
+507
New +$288K ﹤0.01% 719

Other funds holding KPTI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Numeric Investors's KPTI Position: Q2 2016 in Review

Numeric Investors sold out of Karyopharm Therapeutics (KPTI) in Q2 2016, closing a stake of 2,855 shares — an estimated $382K sold.

Numeric Investors first reported a position in KPTI in Q4 2014 and held it in 2 quarters. The position peaked at $382K in Q1 2016. 75 funds tracked by Wall St. Rank hold KPTI as of Q2 2016.

  • Numeric Investors reported no remaining Karyopharm Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Numeric Investors sold 2,855 Karyopharm Therapeutics shares in Q2 2016, an estimated $382K.
  • Numeric Investors first reported a position in Karyopharm Therapeutics in Q4 2014 and held it in 2 quarters.
  • Numeric Investors's Karyopharm Therapeutics position peaked at $382K in Q1 2016.
  • 75 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2016.

Based on Numeric Investors's 13F filing for Q2 2016, filed 16 Aug 2016.